Picture of Neuronetics logo

STIM Neuronetics News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareSpeculativeSmall CapNeutral

Neuronetics Inc expected to post a loss of 31 cents a share - Earnings Preview

* Neuronetics Inc  STIM.OQ   STIM.O  is expected to show a
rise in
quarterly revenue when it reports  results on May 7 for the
period ending March 31 2024
    * The Malvern Pennsylvania-based  company is expected to
report a
10.2% increase in revenue to $17.122 million from $15.54 million
a year ago, according to the mean estimate from 4 analysts,
based on LSEG data.The company's guidance on March 5 2024, for
the period ended March 31, was for revenue between $16.70
million and $17.70 million.
    * ​LSEG's mean analyst estimate for Neuronetics Inc is for a
loss
of 31 cents per share. 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 3 "strong buy" or "buy," 1
"hold" and no "sell" or "strong sell."  
    * The mean earnings estimate of analysts was unchanged in
the last
three months. ​
    * Wall Street's median 12-month price target for Neuronetics
Inc
is $7.00​, above​ its last closing price of $3.50. ​​​

Previous quarterly performance (using preferred earnings measure
in US dollars). ​
 QUARTER       STARMINESM  LSEG IBES  ACTUAL    BEAT,   SURPRI
 ENDING        ARTESTIMAT  ESTIMATE             MET,    SE %
               E®                               MISSED  
 Jan. 1 0001   -0.26       -0.26      -0.19     Beat    27.3
 Jun. 30 0001  -0.31       -0.31      -0.33     Missed  -6.7
 Jan. 1 0001   -0.35       -0.35      -0.17     Beat    51.2​
 Jan. 1 0001   -0.39       -0.39      -0.38     Beat    2.1
 ​​Sep.        -0.35       -0.42      -0.30     Beat    21.3
 30 2022                                                
 Sep. 30 2022  -0.42       -0.42      -0.28     Beat    33.5​
 Jun. 30 2022  -0.41       -0.41      -0.39     Beat    5.3
 Jan. 1 0001   -0.40       -0.40      -0.41     Missed  -2.6
 This summary was machine generated May 3 at 13:00 GMT.  All
figures in US dollars unless otherwise stated. (For questions
concerning the data in this report, contact
Estimates.Support@lseg.com. For any other questions or feedback,
contact RefinitivNewsSupport@thomsonreuters.com)

Recent news on Neuronetics

See all news